72 related articles for article (PubMed ID: 8683296)
1. Targeting of glucose transport proteins for tumor imaging: is it feasible?
Nelson CA; Wang QJ; Bourque JP; Crane PD
J Nucl Med; 1996 Jun; 37(6):1031-7. PubMed ID: 8683296
[TBL] [Abstract][Full Text] [Related]
2. Interaction of aminoalkylcarbamates of forskolin with adenylyl cyclase: synthesis of an iodinated derivative of forskolin with high affinity for adenylyl cyclase.
Laurenza A; Robbins JD; Seamon KB
Mol Pharmacol; 1992 Feb; 41(2):360-8. PubMed ID: 1538712
[TBL] [Abstract][Full Text] [Related]
3. Targeting glucose transporters for tumor imaging: "sweet" idea, "sour" result.
Wahl RL
J Nucl Med; 1996 Jun; 37(6):1038-41. PubMed ID: 8683297
[No Abstract] [Full Text] [Related]
4. [125I]-labeled forskolin analogs which discriminate adenylyl cyclase and a glucose transporter: pharmacological characterization and localization of binding sites in rat brain by in vitro receptor autoradiography.
Appel NM; Robbins JD; De Souza EB; Seamon KB
J Pharmacol Exp Ther; 1992 Dec; 263(3):1415-23. PubMed ID: 1469642
[TBL] [Abstract][Full Text] [Related]
5. The interaction among glucose transport, hexokinase, and glucose-6-phosphatase with respect to 3H-2-deoxyglucose retention in murine tumor models.
Nelson CA; Wang JQ; Leav I; Crane PD
Nucl Med Biol; 1996 May; 23(4):533-41. PubMed ID: 8832712
[TBL] [Abstract][Full Text] [Related]
6. FDG uptake and glucose transporter subtype expressions in experimental tumor and inflammation models.
Mochizuki T; Tsukamoto E; Kuge Y; Kanegae K; Zhao S; Hikosaka K; Hosokawa M; Kohanawa M; Tamaki N
J Nucl Med; 2001 Oct; 42(10):1551-5. PubMed ID: 11585872
[TBL] [Abstract][Full Text] [Related]
7. Photoaffinity labeling of the stereospecific D-glucose transport system with cytochalasin B.
Pessin JE; Tillotson LG; Isselbacher KJ; Czech MP
Fed Proc; 1984 May; 43(8):2258-61. PubMed ID: 6538854
[TBL] [Abstract][Full Text] [Related]
8. Targeting sigma receptor-binding benzamides as in vivo diagnostic and therapeutic agents for human prostate tumors.
John CS; Vilner BJ; Geyer BC; Moody T; Bowen WD
Cancer Res; 1999 Sep; 59(18):4578-83. PubMed ID: 10493511
[TBL] [Abstract][Full Text] [Related]
9. pH in human tumor xenografts and transplanted rat tumors: effect of insulin, inorganic phosphate, and m-iodobenzylguanidine.
Jähde E; Volk T; Atema A; Smets LA; Glüsenkamp KH; Rajewsky MF
Cancer Res; 1992 Nov; 52(22):6209-15. PubMed ID: 1423263
[TBL] [Abstract][Full Text] [Related]
10. Transmembrane glucose carriers in the monkey lens. Quantitation and regional distribution as determined by cytochalasin B binding to lens membranes.
Lucas VA; Zigler JS
Invest Ophthalmol Vis Sci; 1987 Aug; 28(8):1404-12. PubMed ID: 3610555
[TBL] [Abstract][Full Text] [Related]
11. Evidence that forskolin binds to the glucose transporter of human erythrocytes.
Lavis VR; Lee DP; Shenolikar S
J Biol Chem; 1987 Oct; 262(30):14571-5. PubMed ID: 3667590
[TBL] [Abstract][Full Text] [Related]
12. Cytochalasin B does not serve as a marker of glucose transport in rabbit erythrocytes.
Albert SG
Biochem Int; 1984 Jul; 9(1):93-103. PubMed ID: 6541046
[TBL] [Abstract][Full Text] [Related]
13. Cholecystokinin-B/gastrin receptor binding peptides: preclinical development and evaluation of their diagnostic and therapeutic potential.
Behr TM; Béhé M; Angerstein C; Gratz S; Mach R; Hagemann L; Jenner N; Stiehler M; Frank-Raue K; Raue F; Becker W
Clin Cancer Res; 1999 Oct; 5(10 Suppl):3124s-3138s. PubMed ID: 10541353
[TBL] [Abstract][Full Text] [Related]
14. Glut-1 and hexokinase expression: relationship with 2-fluoro-2-deoxy-D-glucose uptake in A431 and T47D cells in culture.
Aloj L; Caracó C; Jagoda E; Eckelman WC; Neumann RD
Cancer Res; 1999 Sep; 59(18):4709-14. PubMed ID: 10493529
[TBL] [Abstract][Full Text] [Related]
15. Rapid and specific targeting of 125I-labeled B lymphocyte stimulator to lymphoid tissues and B cell tumors in mice.
Riccobene TA; Miceli RC; Lincoln C; Knight Y; Meadows J; Stabin MG; Sung C
J Nucl Med; 2003 Mar; 44(3):422-33. PubMed ID: 12621010
[TBL] [Abstract][Full Text] [Related]
16. The glucose transporter of the human brain and blood-brain barrier.
Kalaria RN; Gravina SA; Schmidley JW; Perry G; Harik SI
Ann Neurol; 1988 Dec; 24(6):757-64. PubMed ID: 3207358
[TBL] [Abstract][Full Text] [Related]
17. Expression of GLUT-1 glucose transporter in borderline and malignant epithelial tumors of the ovary.
Cantuaria G; Magalhaes A; Penalver M; Angioli R; Braunschweiger P; Gomez-Marin O; Kanhoush R; Gomez-Fernandez C; Nadji M
Gynecol Oncol; 2000 Oct; 79(1):33-7. PubMed ID: 11006027
[TBL] [Abstract][Full Text] [Related]
18. Asparagine 394 in putative helix 11 of the galactose-H+ symport protein (GalP) from Escherichia coli is associated with the internal binding site for cytochalasin B and sugar.
McDonald TP; Walmsley AR; Henderson PJ
J Biol Chem; 1997 Jun; 272(24):15189-99. PubMed ID: 9182541
[TBL] [Abstract][Full Text] [Related]
19. Human erythrocyte sugar transport is incompatible with available carrier models.
Cloherty EK; Heard KS; Carruthers A
Biochemistry; 1996 Aug; 35(32):10411-21. PubMed ID: 8756697
[TBL] [Abstract][Full Text] [Related]
20. Intratumoral distribution of tritiated-FDG in breast carcinoma: correlation between Glut-1 expression and FDG uptake.
Brown RS; Leung JY; Fisher SJ; Frey KA; Ethier SP; Wahl RL
J Nucl Med; 1996 Jun; 37(6):1042-7. PubMed ID: 8683298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
